Administration of vasopressors through peripheral venous catheters.
作者信息
Araiza Alan, Duran Melanie, Varon Joseph
机构信息
United Memorial Medical Center (Araiza, Duran, Varon), Houston, Tex.; Universidad Autónoma de Baja California (Araiza), Tijuana, México; Universidad Xochicalco (Duran), Ensenada, México; The University of Houston School of Medicine (Varon), Houston, Tex.
出版信息
CMAJ. 2022 May 30;194(21):E739. doi: 10.1503/cmaj.211966.
Abstract
摘要
相似文献
1
Administration of vasopressors through peripheral venous catheters.通过外周静脉导管给予血管升压药。
CMAJ. 2022 May 30;194(21):E739. doi: 10.1503/cmaj.211966.
2
Complications from Administration of Vasopressors Through Peripheral Venous Catheters: An Observational Study.通过外周静脉导管使用血管升压药的并发症：一项观察性研究。
J Emerg Med. 2018 Jan;54(1):47-53. doi: 10.1016/j.jemermed.2017.09.007. Epub 2017 Oct 27.
3
Safety and efficacy of vasopressor administration through midline catheters.通过中线导管给予血管加压药的安全性和有效性。
J Crit Care. 2021 Feb;61:1-4. doi: 10.1016/j.jcrc.2020.09.024. Epub 2020 Oct 2.
4
A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters.关于通过外周静脉导管和中心静脉导管给予血管升压药引起的外渗和局部组织损伤的系统评价。
J Crit Care. 2015 Jun;30(3):653.e9-17. doi: 10.1016/j.jcrc.2015.01.014. Epub 2015 Jan 22.
5
Variation of arterial and central venous catheter use in United States intensive care units.美国重症监护病房中动脉和中央静脉导管使用的变化。
Anesthesiology. 2014 Mar;120(3):650-64. doi: 10.1097/ALN.0000000000000008.
6
Complication of vasopressor infusion through peripheral venous catheter: A systematic review and meta-analysis.外周静脉导管输注血管加压素的并发症：系统评价和荟萃分析。
Am J Emerg Med. 2020 Nov;38(11):2434-2443. doi: 10.1016/j.ajem.2020.09.047. Epub 2020 Sep 28.
7
Safety of the Peripheral Administration of Vasopressor Agents.血管加压药外周给药的安全性。
J Intensive Care Med. 2019 Jan;34(1):26-33. doi: 10.1177/0885066616686035. Epub 2017 Jan 11.
8
Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: A retrospective cohort study.早期感染性休克患者经外周与中心静脉通路输注血管活性药物的比较：一项回顾性队列研究
Emerg Med Australas. 2020 Apr;32(2):210-219. doi: 10.1111/1742-6723.13394. Epub 2019 Oct 9.
9
[Field 6. Safety practices for haemodynamic procedures (administration of vasoactive drugs, vascular and cardiac catheterization). French-speaking Society of Intensive Care. French Society of Anesthesia and Resuscitation].[第6部分. 血流动力学操作的安全规范（血管活性药物的给药、血管及心脏导管插入术）。法语区重症监护学会。法国麻醉与复苏学会]
Ann Fr Anesth Reanim. 2008 Oct;27(10):e91-9. doi: 10.1016/j.annfar.2008.09.012. Epub 2008 Oct 25.
10
Can Vasopressors Safely Be Administered Through Peripheral Intravenous Catheters Compared With Central Venous Catheters?与中心静脉导管相比，血管升压药通过外周静脉导管给药是否安全？
Ann Emerg Med. 2015 Dec;66(6):629-31. doi: 10.1016/j.annemergmed.2015.05.026. Epub 2015 Jul 23.
引用本文的文献
1
Early initiated noradrenaline versus fluid therapy for hypotension and shock in the emergency department (VASOSHOCK): a protocol for a pragmatic, multi-center, superiority, randomized controlled trial.急诊科早期应用去甲肾上腺素与液体疗法治疗低血压和休克（VASOSHOCK）：一项实用、多中心、优效性、随机对照试验方案
Scand J Trauma Resusc Emerg Med. 2025 Apr 7;33(1):59. doi: 10.1186/s13049-025-01369-4.
2
[Ten key statements on the guideline "Peripheral administration of vasopressors"].关于“血管升压药的外周给药”指南的十条关键声明
Med Klin Intensivmed Notfmed. 2025 Mar;120(2):135-137. doi: 10.1007/s00063-024-01201-4. Epub 2024 Nov 12.
本文引用的文献
1
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动：2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
2
Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis.外周静脉导管给药时与血管加压药物相关的不良事件：系统评价和荟萃分析。
Crit Care. 2021 Apr 16;25(1):146. doi: 10.1186/s13054-021-03553-1.
3
Socio-demographic characteristics associated with hospitalization for sepsis among adults in Canada: a Census-linked cohort study.与加拿大成年人脓毒症住院相关的社会人口学特征：一项基于人口普查的队列研究。
Can J Anaesth. 2020 Apr;67(4):408-420. doi: 10.1007/s12630-019-01536-z. Epub 2019 Dec 2.
4
Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.延迟血管升压药的使用与感染性休克患者死亡率的增加有关。
J Crit Care. 2020 Feb;55:145-148. doi: 10.1016/j.jcrc.2019.11.004. Epub 2019 Nov 9.
5
A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters.关于通过外周静脉导管和中心静脉导管给予血管升压药引起的外渗和局部组织损伤的系统评价。
J Crit Care. 2015 Jun;30(3):653.e9-17. doi: 10.1016/j.jcrc.2015.01.014. Epub 2015 Jan 22.
Zotero 插件